Prostate cancer is one of the common cancers diagnosed each year in males. In this new series, we will go through the ins-and-outs of this disease. As medical oncologists, there is so much more to prostate cancer than we see. In our future episodes, we will also highlight the important role of pharmacists, radiation oncologists, and urologists in disease management! Content: - What is the incidence of prostate cancer? - What are the screening guideline recommendations?- How do we diagnose prostate cancer?- How do we risk stratify patients with prostate cancer?- What additional imaging, if any, is needed as part of our workup of prostate cancer? - What is the overview regarding treatment of prostate cancer?- What is the overview about what to expect after surgery or radiation for prostate cancer? - What are key terms we need to know in prostate cancer? ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast

Pharmacist Renee McAllister discusses managing extravasation accidents, pharmacy operations, ideal body weight vs. AUC, giving G-CSF, and supportive care tips in hematology and oncology. They also emphasize the importance of staffing and safety checks in administering inpatient chemo, relying on primary sources for drug information, and the role of pharmacists in chemotherapy management.

The podcast discusses the basics of pharmacology in oncology, including the differences between irritants and vesicants, the need for central access in patients receiving therapy, and an overview of chemotherapy side effects.

The hosts discuss the importance of understanding chemotherapy fundamentals, counseling patients, and administering drugs. They explore treatment regimens, valuable resources, and the three main categories of chemotherapy: cytotoxic, immune, and targeted therapy. The chapter also covers important aspects of chemotherapy and previews upcoming topics.

Explore warfarin and enoxaparin failure in the context of anticoagulation. Discuss alternative options for patients with anti-phospholipid antibody syndrome (APLS) whose warfarin treatment failed. Learn about distinguishing new and residual clots on imaging and the implications. Understand APLS, its impact on lab testing, and accurate diagnosis. Explore the correlation between INR values and factor 10 activity in patients with lupus anticoagulants.

This podcast discusses the workup for anticoagulation failure, focusing on DOAC failure. They explore challenges and considerations, including verifying blood thinner levels, assessing patient adherence, and exploring anatomic reasons for clot formation. They also discuss alternative anticoagulants like warfarin.

In this FINAL episode of our DLBCL series, we build on our conversation from last week, focusing on the management of relapsed DLBCL. If you have not done so already, we recommend you check out Episode 077! Content: - Treatment with selective antibodies against CD19- How to approach relapsed disease after CAR-T - Use of BiTE therapy - Role of allo? ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast

In our last episode, we discussed our approach to primary refractory DLBCL. This week, we start our conversation about relapsed DLBCL! This is an important and complex discussion, so we have split it into two episodes to help you follow along. If you have not done so already, we recommend you check out episode 076 for a discussion about the primary refractory setting.Content: - Approach to relapsed disease (after 12 months)- How to approach relapse with CNS involvement- Role of CAR-T vs. autologous transplant in this setting- How to approach treatment in patients who are poor candidates for auto or CAR-T** This episode is sponsored by HemOnc.org** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast

This week, we pick up on our discussion about management of DLBCL, focusing on the primary refractory setting. A big part of this discussion is the role of CAR-T therapy. If you have not done so already, we highly recommend you check out episode 075 for the fundamentals of CAR-T before proceeding with this episode!Content: - Definitions for "primary refractory" vs. "relapsed" disease- How do we approach patients with primary refractory disease? - What are the treatment regimens for patients with primary refractory disease?- What is the role of CAR-T therapy? - How do we "bridge" patients to CAR-T therapy? - How do we monitor patients post CAR-T? ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast

In this week’s episode, we pause from our discussion about DLBCL to talk about the fundamentals of CAR-T, BiTE and autologous transplants, which will lay the foundation for subsequent discussions about DLBCL. These therapies are the talk of the town and have changed/will continue to change our approach to hematologic malignancies - definitely an episode you don’t want to miss. Content: - What is CAR-T?- How are CAR-T cells manufactured?- What are commercially available CAR-T cell products? - What are side effects of CAR-T? - What is BiTE therapy?- What is the role of autologous transplants in lymphoma? ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast